These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 30609381)
21. Direct Compression Tablet Containing 99% Active Ingredient-A Tale of Spherical Crystallization. Chen H; Aburub A; Sun CC J Pharm Sci; 2019 Apr; 108(4):1396-1400. PubMed ID: 30448523 [TBL] [Abstract][Full Text] [Related]
22. Particle Engineering for Enabling a Formulation Platform Suitable for Manufacturing Low-Dose Tablets by Direct Compression. Sun WJ; Aburub A; Sun CC J Pharm Sci; 2017 Jul; 106(7):1772-1777. PubMed ID: 28322940 [TBL] [Abstract][Full Text] [Related]
23. Spray drying ternary amorphous solid dispersions of ibuprofen - An investigation into critical formulation and processing parameters. Ziaee A; Albadarin AB; Padrela L; Faucher A; O'Reilly E; Walker G Eur J Pharm Biopharm; 2017 Nov; 120():43-51. PubMed ID: 28822874 [TBL] [Abstract][Full Text] [Related]
24. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes. Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069 [TBL] [Abstract][Full Text] [Related]
25. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug. Alyami H; Dahmash E; Bowen J; Mohammed AR PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454 [TBL] [Abstract][Full Text] [Related]
26. Drug release characteristics from nanoclay hybrids and their dispersions in organic polymers. Ha JU; Xanthos M Int J Pharm; 2011 Jul; 414(1-2):321-31. PubMed ID: 21601624 [TBL] [Abstract][Full Text] [Related]
27. Downstream processing of a ternary amorphous solid dispersion: The impacts of spray drying and hot melt extrusion on powder flow, compression and dissolution. Davis MT; Potter CB; Walker GM Int J Pharm; 2018 Jun; 544(1):242-253. PubMed ID: 29689366 [TBL] [Abstract][Full Text] [Related]
29. Monitoring process induced attrition of drug substance particles within formulated blends. Gamble JF; Hoffmann M; Hughes H; Hutchins P; Tobyn M Int J Pharm; 2014 Aug; 470(1-2):77-87. PubMed ID: 24793838 [TBL] [Abstract][Full Text] [Related]
30. Simplified end-to-end continuous manufacturing by feeding API suspensions in twin-screw wet granulation. Schmidt A; de Waard H; Moll KP; Kleinebudde P; Krumme M Eur J Pharm Biopharm; 2018 Dec; 133():224-231. PubMed ID: 30291963 [TBL] [Abstract][Full Text] [Related]
31. Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations. Gikanga B; Hui A; Maa YF PDA J Pharm Sci Technol; 2018; 72(2):117-133. PubMed ID: 29030532 [TBL] [Abstract][Full Text] [Related]
32. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets. Lin SY; Lin KH; Li MJ J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050 [TBL] [Abstract][Full Text] [Related]
33. Understanding the Factors That Control the Quality of Mini-Tablet Compression: Flow, Particle Size, and Tooling Dimension. Zhao J; Yin D; Rowe J; Badawy S; Nikfar F; Pandey P J Pharm Sci; 2018 Apr; 107(4):1204-1208. PubMed ID: 29233726 [TBL] [Abstract][Full Text] [Related]
34. Nanoamorphous drug products - Design and development. Jog R; Burgess DJ Int J Pharm; 2018 Dec; 553(1-2):238-260. PubMed ID: 30359685 [TBL] [Abstract][Full Text] [Related]
35. The influence of direct compression powder blend transfer method from the container to the tablet press on product critical quality attributes: a case study. Teżyk M; Jakubowska E; Milczewska K; Milanowski B; Voelkel A; Lulek J Drug Dev Ind Pharm; 2017 Jun; 43(6):911-916. PubMed ID: 28032521 [TBL] [Abstract][Full Text] [Related]
36. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold. Wenzel T; Stillhart C; Kleinebudde P; Szepes A Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095 [TBL] [Abstract][Full Text] [Related]
37. Advances in Polymer Design for Enhancing Oral Drug Solubility and Delivery. Ting JM; Porter WW; Mecca JM; Bates FS; Reineke TM Bioconjug Chem; 2018 Apr; 29(4):939-952. PubMed ID: 29319295 [TBL] [Abstract][Full Text] [Related]
38. Modification of α-lactose monohydrate as a direct compression excipient using roller compaction. Abu Fara D; Rashid I; Alkhamis K; Al-Omari M; Chowdhry BZ; Badwan A Drug Dev Ind Pharm; 2018 Dec; 44(12):2038-2047. PubMed ID: 30095020 [TBL] [Abstract][Full Text] [Related]
39. Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery. Ogáin ON; Li J; Tajber L; Corrigan OI; Healy AM Int J Pharm; 2011 Feb; 405(1-2):23-35. PubMed ID: 21129458 [TBL] [Abstract][Full Text] [Related]
40. Downstream processing of polymer-based amorphous solid dispersions to generate tablet formulations. Démuth B; Nagy ZK; Balogh A; Vigh T; Marosi G; Verreck G; Van Assche I; Brewster ME Int J Pharm; 2015; 486(1-2):268-86. PubMed ID: 25827903 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]